SweetValueLab
Write for us

Revvity, Inc. — Financial Statements & Ratios

RVTY
NYSEHealthcareMedical - Diagnostics & ResearchCIK 0000031791revvity.comAbout RVTY
Last close · Oct 16, 2026152.64−2.07 (−1.34%)
Market cap$17.0B

Key indicators

Revenue2.9BTTM+4.1% on a year earlier+0.4% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2021FY2022FY2023FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
2.8B 2.9B+3.8%3.8B+31.2%5.1B+34.0%3.3B−34.6%2.8B−16.9%2.8B+0.2%2.9B+3.7%2.9B+4.1%2.9B 3.0B 3.2B
— 3.8% 31.2% 34.0% -34.6% -16.9% 0.2% 3.7% 4.1% -0.1% 5.4% 5.8%
$2.13 $2.04−4.2%$6.49+218.1%$8.08+24.5%$4.50−44.3%$5.55+23.3%$2.20−60.4%$2.07−5.9%$2.09−11.4%$5.36 $5.89 $6.46
Profitability
48.3% 48.4%+0.1 pt55.8%+7.4 pt48.0%−7.7 pt60.1%+12.0 pt— — — — · · ·
11.7% 12.6%+0.9 pt25.9%+13.3 pt26.3%+0.4 pt22.4%−3.9 pt10.9%−11.5 pt12.6%+1.7 pt12.5%−0.1 pt12.3%−1.3 pt· · ·
8.6% 7.9%−0.7 pt19.2%+11.4 pt18.6%−0.6 pt17.2%−1.4 pt25.2%+8.0 pt9.8%−15.4 pt8.4%−1.4 pt8.2%−2.0 pt· · ·
9.2% 8.1%−1.1 pt19.5%+11.4 pt13.2%−6.3 pt7.7%−5.5 pt8.8%+1.1 pt3.5%−5.3 pt3.3%−0.2 pt— · · ·
Cash
217.8M 287.1M+31.8%814.7M+183.7%1.3B+60.9%594.2M−54.7%9.9M−98.3%541.7M+5369.0%509.4M−6.0%558.1M+11.0%· · ·
7.8% 10.0%+2.1 pt21.5%+11.6 pt25.9%+4.3 pt17.9%−7.9 pt0.4%−17.6 pt19.7%+19.3 pt17.8%−1.8 pt19.2%+1.2 pt· · ·
31.0M 31.1M+0.2%31.2M+0.5%32.4M+3.7%35.3M+9.2%35.0M−1.1%34.5M−1.5%32.8M−4.8%— · · ·
Balance sheet
0.73x 0.73x+0.01x0.53x−0.20x0.70x+0.16x0.60x−0.10x0.50x−0.10x0.41x−0.08x0.44x+0.03x0.44x+0.02x· · ·
111.53M 111.50M−0.0%112.08M+0.5%116.67M+4.1%126.43M+8.4%124.81M−1.3%122.82M−1.6%116.59M−5.1%111.63M−5.0%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jul 5, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.